Racial/ethnic differences in US drug overdose mortality, 2017-2018
Racial/ethnic differences in US drug overdose mortality, 2017-2018
复制标题
DOI：
10.1016/j.addbeh.2020.106625
复制
发表时间：
2021-01-01
影响因子：
4.4
通讯作者：
Cano, Manuel
中科院分区：
文献类型：
--
作者：
Cano, Manuel
背景：2018年是自1999年以来美国吸毒过量死亡人数较前一年首次下降的一年。然而，目前还不清楚是否所有种族/民族都出现了这种下降。方法：检查了国家卫生统计中心的死亡证明数据，以确定特定种族和民族的美国居民是否吸毒过量(2017年为69,764人，2018年为66,949人)。2017年和2018年的特定年龄和调整后的药物过量死亡率按种族/族裔、总体、性别和涉及兴奋剂的药物过量进行了比较。结果：从2017年到2018年，非西班牙裔白人的年龄调整后的药物过量死亡率显著下降，而在西班牙裔白人中，年龄调整后的药物过量死亡率显著上升。从2017年到2018年，NH黑人男性、西班牙裔男性和65岁及以上的NH黑人的药物过量死亡率显著上升，涉及精神刺激剂(在所有种族/族裔群体中)和可卡因(在NH黑人和西班牙裔美国人中)的药物过量死亡率也显著上升。2018年，涉及阿片类药物过量死亡的比例在NH亚太岛民中为43.2%，在NH白人中为70.8%，阿片类药物共同参与兴奋剂过量死亡的水平也因种族/民族而异。结论：美国不断演变的过量药物危机需要不断演变的应对措施，不仅要解决与过量死亡最相关的药物组合的变化，而且要加强针对种族/少数民族群体的干预。
Background: The year 2018 marked the first year since 1999 in which the number of drug overdose deaths in the United States (US) declined compared to the previous year. However, it is unclear whether this decline was observed across all racial/ethnic groups.Methods: Death certificate data from the National Center for Health Statistics were examined for drug overdoses among US residents with a race and ethnicity specified (69,764 in 2017 and 66,949 in 2018). Age-specific and age-adjusted drug overdose mortality rates for 2017 and 2018 were compared by race/ethnicity, overall, by sex, and for overdoses involving stimulants. Percentages of overdose deaths involving specific drug combinations were computed by race/ethnicity.Results: From 2017 to 2018, the age-adjusted drug overdose mortality rate significantly decreased in Non-Hispanic (NH) Whites; among Hispanics, in contrast, a significant increase was observed. Significant increases in drug overdose mortality rates from 2017 to 2018 were observed for NH Black males, Hispanic males, and NH Blacks aged 65 and older, as well as for overdoses involving psychostimulants (in all racial/ethnic groups) and cocaine (in NH Blacks and Hispanics). In 2018, the proportion of drug overdose deaths involving opioids ranged from 43.2% among NH Asian/Pacific Islanders to 70.8% among NH Whites, and the level of opioid co-involvement in stimulant-involved overdose deaths also varied by race/ethnicity.Conclusions: The continually-evolving US overdose crisis necessitates an evolving response, not only to address changes in the drug combinations most involved in overdose deaths, but also to strengthen interventions targeting racial/ethnic minority groups.